SCHEMBL4079510

SCHEMBL4079510

CC(C)(C)N1CCC[C@@H](C(=O)c2cc(F)cc(Cl)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM2B Q8NHM5 8/20 0.44
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MGLL Q99685 1/20 0.41
CACNA1G O43497 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNA1I Q9P0X4 1/20 0.41
PDE2A O00408 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975598 0.81 MEN1 (0.53) KDM2BMEN1KMT2AALDH1A1MGLL
SCHEMBL3965621 0.81 KDM2B (0.66) KDM2BMEN1KMT2AALDH1A1
SCHEMBL1857032 0.81 MEN1 (0.50) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL2321941 0.81 MEN1 (0.50) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL27778357 0.81 KDM2B (0.40) KDM2BTAS1R3TAS1R1TAS1R2MEN1
SCHEMBL3968256 0.80 ALDH1A1 (0.48) KDM2BMEN1KMT2AALDH1A1MGLL
SCHEMBL2145821 0.73 HSD11B1 (0.53) MEN1KMT2AALDH1A1MGLL
SCHEMBL5318682 0.73 KDM2B (0.49) KDM2BMEN1KMT2AALDH1A1PDE2A
SCHEMBL3966027 0.73 ALDH1A1 (0.52) MEN1KMT2AALDH1A1
SCHEMBL10132433 0.73 ALDH1A1 (0.50) TAS1R3TAS1R1TAS1R2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074108-A1 RENIN INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2009-07-01 EP disclosed
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2008036247-A1 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-03-27 WO disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed